Global Solid Tumor Testing Market 2023 - By Size, Drivers, Trends, Competitors And Forecast To 2032

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Solid Tumor Testing Global Market Report 2023 identifies increase in the prevalence of cancer as the major driver for the Solid Tumor Testing market's growth in the forecast period. Cancer is a condition marked by the body's aberrant cells growing and spreading out of control. These abnormal cells, known as cancer cells, can invade nearby tissues and organs and, in some cases, spread to other parts of the body through the bloodstream or lymphatic system. Most adult cancers are solid tumors, which is about 90%.

The global solid tumor testing market is expected to grow from $23.81 billion in 2022 to $25.74 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The solid tumor testing market is expected to reach $33.91 billion in 2027 at a CAGR of 7.1%.

Download Free Sample Of Solid Tumor Testing Market Report - https://www.thebusinessresearchcompany.com/sample_request?id=12658&type=smp

Major competitors in the Solid Tumor Testing market are Johnson & Johnson Ltd, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Molecular Inc., Becton Dickinson And Company (BD).

A key trend in the Solid Tumor Testing market includes innovative liquid biopsy test solutions. Major companies operating in the solid tumor testing market are focused on developing innovative liquid biopsy test solutions to strengthen their position and gain a competitive advantage in the market. For instance, in June 2020, NeoGenomics Inc., a US-based testing laboratory company, launched its comprehensive suite of three solid tumor liquid biopsy tests for cancer patients. These innovative tests are designed to detect cancer cells in the blood of patients with solid tumors, even if the cancer is not yet visible on imaging tests. The tests can be used to help doctors make decisions about further testing or treatment. Additionally, it is non-invasive, has early detection, can be used to personalize treatment, and is FDA-approved. Moreover, these three new tests also have seven days or fewer turnaround times, which can save clinicians considerable time.

Read More On The Global Solid Tumor Testing Market Report Here:
https://www.thebusinessresearchcompany.com/report/solid-tumor-testing-global-market-report

The Solid Tumor Testing market is segmented -

• By Type: Genetic Testing, Conventional Testing
• By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer
• By Application: Clinical, Research
• By End-Users: Hospitals, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic Research Institutions
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Solid Tumor Testing market.

The Business Research Company's "Global Solid Tumor Testing Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Solid Tumor Testing Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12658

The Table Of Content For The Solid Tumor Testing Market Include:

1. Executive Summary
2. Solid Tumor Testing Market Characteristics
3. Solid Tumor Testing Market Trends And Strategies
4. Solid Tumor Testing Market - Macro Economic Scenario
5. Global Solid Tumor Testing Market Drivers and Restraints
………………………………….
32. Global Solid Tumor Testing Market Competitive Benchmarking
33. Global Solid Tumor Testing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Solid Tumor Testing Market
35. Solid Tumor Testing Market Future Outlook and Potential Analysis
36. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.